Another brick in the wall: Adrenomedullin and prognosis in community-acquired pneumonia

European Respiratory Journal

Volumn 39, Issue 5, 2012, Pages 1060-1061

  Krüger, Stefan ^a   Frechen, Dirk ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; C REACTIVE PROTEIN; PROADRENOMEDULLIN; PROCALCITONIN;

CARDIOVASCULAR DISEASE; COMMUNITY ACQUIRED PNEUMONIA; CRB 65 SCORE; EDITORIAL; HIGH RISK PATIENT; HUMAN; LEUKOCYTE COUNT; MORTALITY; PNEUMONIA SEVERITY INDEX; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; SCORING SYSTEM; SEPSIS; SURVIVAL PREDICTION;

ADRENOMEDULLIN; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; PROTEIN PRECURSORS;

EID: 84860463961     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00179911     Document Type: Editorial

References (11)

1. Ewig S, Birkner N, Strauss R, et al. New perspectives on community-acquired pneumonia in 388,406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 2009; 64: 1062-1069.
2. Schuetz P, Albrich W, Christ-Crain M, et al. Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther 2010; 8: 575-587.
3. Krüger S, Ewig S, Giersdorf S, et al. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia. Results from the German competence network CAPNETZ. Am J Respir Crit Care Med 2010; 182: 1426-1434.
4. Krüger S, Ewig S, Marre R, et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 2008; 31: 349-355.
5. Krüger S, Ewig S, Kunde J, et al. Pro-atrial natriuretic peptide and pro-vasopressin to predict short- and long-term survival in community-acquired pneumonia. Results from the German competence network CAPNETZ. Thorax 2010; 65: 208-214.
6. Bello S, Lasierra AB, Mincholé E, et al. Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology. Eur Respir J 2012; 39: 1144-1155.
7. Schuetz P, Wolbers M, Christ-Crain M, et al. Prohormones for prediction of adversemedical outcome in community-acquired pneumonia and lower respiratory tract infections. Crit Care 2010; 14: R106.
8. Christ-Crain M, Morgenthaler NG, Stolz D, et al. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Crit Care 2006; 10: R96.
9. Huang DT, Angus DC, Kellum JA, et al. Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia. Chest 2009; 136: 823-831.
10. Albrich WC, Dusemund F, Rüegger K, et al. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. BMC Infect Dis 2011; 11: 112.
11. Albrich WC, Rüegger K, Dusemund F, et al. Optimised patient transfer using an innovative multidisciplinary assessment in Kanton Aargau (OPTIMA I): an observational survey in lower respiratory tract infections. Swiss Med Wkly 2011; 141: w13237.